Trial intelligence / Profile preview

Calcium Gluconate for the Reduction of Blood Loss During Vaginal Delivery

NCT07714902Recruiting

Sponsor
Rambam Health Care Campus
Start
Jun 2026
Primary completion
Oct 2027
Countries
1
01

Overview

Randomised, double-blind trial in postpartum hemorrhage (PPH) comparing Calcium Gluconate with Placebo (Normal Saline) (2 arms). Primary endpoints: Proportion of Participants With a Hemoglobin Decrease of >=2 g/dL and Mean Change in Hemoglobin Level. Started Jun 2026; status: recruiting.

02

Drugs

calcium gluconate
03

Conditions

postpartum hemorrhage (PPH)

Beyond the preview

Go deeper on NCT07714902.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07714902.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call